Population Pharmacokinetics and Dosing Regimen Analysis of Nirmatrelvir in Chinese Patients with COVID-19 Infection
2024 · Drug Design Development and Therapy · 2 citations
https://doi.org/10.2147/dddt.s479561
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
8
Papers
10
Citations
2
h-index
0
i10-index
Runcong Zhang is an academic researcher from Zhejiang Chinese Medical University. The author has contributed to research in topics: Antibiotics Pharmacokinetics and Efficacy & COVID-19 Clinical Research Studies & Acute Myeloid Leukemia Research. The author has an h-index of 2, co-authored 7 publications.
https://doi.org/10.2147/dddt.s479561
https://doi.org/10.1007/s40268-025-00523-8
Click to start Chat